David Ryan has been named the inaugural president of the Mass General Brigham Cancer Institute
Mass General Brigham posted on LinkedIn:
“We are pleased to announce that David Ryan, MD, has been named the inaugural president of the Mass General Brigham Cancer Institute.
In this role, Dr. Ryan will lead our efforts to build our Cancer Institute, overseeing our clinical care, research, education, and community-based missions, as we work together to enhance quality outcomes for every patient and continue to drive leading-edge discovery and research-infused care.
Dr. Ryan has been a medical oncologist in our system for over two decades and has served as physician-in-chief for the Mass General Brigham Cancer Institute for the past year. He has also served as the chief of hematology/oncology and clinical director of the Mass General Cancer Center since 2012.
As the Shelby Memorial Professor of Medicine at Harvard Medical School, Dr. Ryan’s career is dedicated to serving all patients with cancer, inclusive of his expertise in designing and conducting clinical trials for patients with gastrointestinal cancers. Dr. Ryan’s contributions have earned him recognition on numerous national committees, including multiple task forces for the National Cancer Institute (NCI), the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO).
Join us in sharing our congratulations!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023